AIMEDBIO
IR
ENG
KOR
ABOUT US
Overview
Leadership
Corporate Governance
R&D
AimedBio’s Drug Development
P-ADC™
Pipeline
IR
Disclosure
Stock
Financial Information
PR
Notice
Press Release
Data Room
CAREERS
Our Culture
Disclosure
48 posts
NO.
Title
Date
Author
8
[Corrected description]Registration Statement (Equity securities)
2025-11-17
에임드바이오
7
[Corrected description]Registration Statement (Equity securities)
2025-11-10
에임드바이오
6
[Corrected description]Registration Statement (Equity securities)
2025-10-27
에임드바이오
5
[Added attachment]Registration Statement (Equity securities)
2025-09-29
에임드바이오
4
Consolidated Audit Report (2024.12)
2025-03-31
신한회계법인
3
Audit report (2024.12)
2025-03-31
신한회계법인
2
Consolidated Audit Report (2023.12)
2024-04-03
신한회계법인
1
Audit report (2023.12)
2024-04-03
신한회계법인
[Corrected description]Registration Statement (Equity securities)
에임드바이오
2025-11-17
[Corrected description]Registration Statement (Equity securities)
에임드바이오
2025-11-10
[Corrected description]Registration Statement (Equity securities)
에임드바이오
2025-10-27
[Added attachment]Registration Statement (Equity securities)
에임드바이오
2025-09-29
Consolidated Audit Report (2024.12)
신한회계법인
2025-03-31
Audit report (2024.12)
신한회계법인
2025-03-31
Consolidated Audit Report (2023.12)
신한회계법인
2024-04-03
Audit report (2023.12)
신한회계법인
2024-04-03
1
2
3
4
5
